Stiefl N - Search Results

1

Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.

Zlotos DP, Gündisch D, Ferraro S, Tilotta MC, Stiefl N, Baumann K. Zlotos DP, et al. Among authors: stiefl n. Bioorg Med Chem. 2004 Dec 1;12(23):6277-85. doi: 10.1016/j.bmc.2004.08.053. Bioorg Med Chem. 2004. PMID: 15519170

2

Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.

Stiefl N, Baumann K. Stiefl N, et al. J Med Chem. 2003 Apr 10;46(8):1390-407. doi: 10.1021/jm021077w. J Med Chem. 2003. PMID: 12672239

3

Evaluation of extended parameter sets for the 3D-QSAR technique MaP: implications for interpretability and model quality exemplified by antimalarially active naphthylisoquinoline alkaloids.

Stiefl N, Bringmann G, Rummey C, Baumann K. Stiefl N, et al. J Comput Aided Mol Des. 2003 May-Jun;17(5-6):347-65. doi: 10.1023/a:1026125706388. J Comput Aided Mol Des. 2003. PMID: 14635727

4

Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.

Kapková P, Stiefl N, Sürig U, Engels B, Baumann K, Holzgrabe U. Kapková P, et al. Among authors: stiefl n. Arch Pharm (Weinheim). 2003 Nov;336(11):523-40. doi: 10.1002/ardp.200300795. Arch Pharm (Weinheim). 2003. PMID: 14639745

5

Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems.

Zlotos DP, Buller S, Stiefl N, Baumann K, Mohr K. Zlotos DP, et al. Among authors: stiefl n. J Med Chem. 2004 Jul 1;47(14):3561-71. doi: 10.1021/jm0311341. J Med Chem. 2004. PMID: 15214783

6

Validation tools for variable subset regression.

Baumann K, Stiefl N. Baumann K, et al. Among authors: stiefl n. J Comput Aided Mol Des. 2004 Jul-Sep;18(7-9):549-62. doi: 10.1007/s10822-004-4071-5. J Comput Aided Mol Des. 2004. PMID: 15729854

7

Structure-based validation of the 3D-QSAR technique MaP.

Stiefl N, Baumann K. Stiefl N, et al. J Chem Inf Model. 2005 May-Jun;45(3):739-49. doi: 10.1021/ci049683i. J Chem Inf Model. 2005. PMID: 15921463

8

Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor.

Martina E, Stiefl N, Degel B, Schulz F, Breuning A, Schiller M, Vicik R, Baumann K, Ziebuhr J, Schirmeister T. Martina E, et al. Among authors: stiefl n. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5365-9. doi: 10.1016/j.bmcl.2005.09.012. Epub 2005 Oct 10. Bioorg Med Chem Lett. 2005. PMID: 16216498 Free PMC article.

9

A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.

Kaeppler U, Stiefl N, Schiller M, Vicik R, Breuning A, Schmitz W, Rupprecht D, Schmuck C, Baumann K, Ziebuhr J, Schirmeister T. Kaeppler U, et al. Among authors: stiefl n. J Med Chem. 2005 Nov 3;48(22):6832-42. doi: 10.1021/jm0501782. J Med Chem. 2005. PMID: 16250642

10

ErG: 2D pharmacophore descriptions for scaffold hopping.

Stiefl N, Watson IA, Baumann K, Zaliani A. Stiefl N, et al. J Chem Inf Model. 2006 Jan-Feb;46(1):208-20. doi: 10.1021/ci050457y. J Chem Inf Model. 2006. PMID: 16426057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters